Literature DB >> 24969081

Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus.

T P Mikołajczyk1, D Skiba2, B Batko3, M Krezelok3, G Wilk2, G Osmenda2, J R Pryjma4, T J Guzik5.   

Abstract

Efficient removal of apoptotic polymorphonuclear leukocytes (PMNs) is an important step in the resolution of inflammation, which protects tissues from the noxious contents of dying cells. While the impairment of apoptotic PMNs removal has been demonstrated for macrophages in systemic lupus erythematosus (SLE), recent studies show that monocytes are also capable of such phagocytosis, although their involvement in SLE is not clear. Therefore, we characterized phagocytosis of apoptotic PMNs by monocytes in 22 patients with SLE and 22 healthy controls. Using flow cytometry we demonstrate that in SLE peripheral blood monocytes show impaired phagocytosis of autologous apoptotic PMNs, while they efficiently engulf apoptotic PMNs isolated from healthy subjects. Monocytes CD14highCD16+ and CD14dimCD16+ more efficiently interacted with apoptotic neutrophils than CD16- cells both in SLE and healthy subjects. Monocytes in SLE showed modestly decreased expression of CD35 and CD91 and increased expression of T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3); however, these differences were evident mainly in selected subsets of monocytes (CD16+) while defects in phagocytosis were observed in all monocyte subsets. Apoptotic cell-dependent induction of lipopolysaccharide (LPS) stimulated production of anti-inflammatory cytokine IL-10 by peripheral blood mononuclear cells (PBMC) was blunted in SLE while the production of pro-inflammatory cytokine TNF-α was unchanged.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Systemic lupus erythematosus; monocyte; neutrophil; phagocytosis

Mesh:

Substances:

Year:  2014        PMID: 24969081     DOI: 10.1177/0961203314541316

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

Review 1.  Towards a pro-resolving concept in systemic lupus erythematosus.

Authors:  Sebastian Boeltz; Melanie Hagen; Jasmin Knopf; Aparna Mahajan; Maximilian Schick; Yi Zhao; Cornelia Erfurt-Berge; Jürgen Rech; Luis E Muñoz; Martin Herrmann
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

2.  Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus.

Authors:  T P Mikołajczyk; G Osmenda; B Batko; G Wilk; M Krezelok; D Skiba; T Sliwa; J R Pryjma; T J Guzik
Journal:  Lupus       Date:  2015-08-06       Impact factor: 2.911

Review 3.  Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity.

Authors:  Stanley Gititu Kimani; Ke Geng; Canan Kasikara; Sushil Kumar; Ganapathy Sriram; Yi Wu; Raymond B Birge
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

4.  Several Critical Cell Types, Tissues, and Pathways Are Implicated in Genome-Wide Association Studies for Systemic Lupus Erythematosus.

Authors:  Lu Liu; Xianyong Yin; Leilei Wen; Chao Yang; Yujun Sheng; Yan Lin; Zhengwei Zhu; Changbing Shen; Yinjuan Shi; Yajie Zheng; Sen Yang; Xuejun Zhang; Yong Cui
Journal:  G3 (Bethesda)       Date:  2016-06-01       Impact factor: 3.154

5.  Percutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations.

Authors:  Pawel Maga; Tomasz P Mikolajczyk; Lukasz Partyka; Marek Krzanowski; Krzysztof P Malinowski; Rafal Nizankowski
Journal:  Biomed Res Int       Date:  2016-10-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.